Can Test Reports Be Reused for Overseas Registration of Rehabilitation Devices?

Key Summary

A professional guide for medical device manufacturers on whether existing test reports can be reused for overseas registration of rehabilitation equipment. Covers regulatory judgment logic, evidence chains, common errors, and preparation checklists.

Can Test Reports Be Reused for Overseas Registration of Rehabilitation Devices?

The reuse of test reports for overseas registration of rehabilitation devices depends on multiple factors, including the target country's regulatory framework, product classification, registration pathway, and differences in testing standards. Manufacturers must first confirm whether the device falls under the target country's medical device regulations, then determine the risk class and registration route, and assess whether existing documentation such as NMPA, CE, FDA, ISO 13485 system files, performance verification reports, risk management documents, and clinical evaluation data can be accepted by the target regulatory authority.

Scope and Core Questions

Rehabilitation devices include rehabilitation training equipment, physiotherapy devices, electrical stimulators, pneumatic therapy devices, and traction devices. These products are typically managed as Class II or Class III medical devices in China, while some are non-medical health devices. When planning overseas entry, manufacturers must first determine whether the device is regulated as a medical device in the target country and its specific risk classification.

The issue of test report reuse often arises after a manufacturer already holds NMPA registration, CE certification, or FDA clearance and wishes to use existing test data for another country's registration application. This is common in GHWP member countries such as Saudi Arabia, UAE, Brazil, Mexico, South Korea, Southeast Asian nations, and some Middle Eastern and Latin American markets.

The core question is not simply whether reports can be reused, but whether they can effectively serve as technical evidence to support registration in the target country. Different countries have varying requirements for testing laboratory qualifications, report formats, standard versions, test items, and even raw data. Submitting reports without local adaptation may result in requests for correction or re-testing.

Registration Decision Logic

First, determine whether the target country regulates the rehabilitation device under its medical device laws. For example, the US FDA generally classifies most rehabilitation devices as Class II, requiring 510(k) submission; under the EU MDR, they may be Class IIa or IIb; Southeast Asian countries may follow the ASEAN Medical Device Directive or have local classification differences.

Second, confirm the risk class and registration path. The risk class determines the depth of technical file review, whether clinical evaluation is required, and whether a quality management system audit is necessary. The same product may be classified differently in different countries. For instance, manual wheelchairs are usually Class I, but electric wheelchairs may be Class II; medium-frequency therapy devices may be managed as active Class II devices in some countries but require a higher class in others.

Third, conduct a gap analysis of existing documentation. List all available test reports, system certificates, clinical evidence, and labeling documents, then compare them item by item against the target country's registration requirements to determine which can be directly referenced, which require supplementary testing, and which must be reissued.

Fourth, clarify the applicant entity. Overseas registration typically requires a local agent or authorized representative. The applicant and certificate holder on the test report must match the registration applicant. If not, a transfer agreement or reissued report may be required.

Fifth, evaluate post-market maintenance requirements. Test reports are not one-time documents. Changes, renewal, and QMS surveillance audits may require updated versions or supplementary test reports. Manufacturers should ensure the sustainability of testing resources in advance.

Documentation and Evidence

Core documentation includes product technical requirements, performance indicator verification reports, electrical safety test reports, EMC test reports, biocompatibility evaluation reports, risk management reports, usability engineering reports, clinical evaluation or clinical evidence, stability and aging test reports, software lifecycle documents, label and instruction manual drafts, quality management system certificates, product photos and model lists, and packaging validation reports.

Whether a test report can be directly reused depends on three dimensions: product model and specification, technical parameters and functional configuration, and production site and process flow. If any change affecting safety or effectiveness occurs, even after the report is issued, re-evaluation or supplementary testing is required.

Laboratory qualification is also critical. Most countries require test laboratories to be accredited to ISO/IEC 17025. Some countries also recognize MDSAP audits or specific mutual recognition agreements. For notified body reports used in CE marking, some GHWP countries may allow direct use, provided the report is issued by a notified body and the standards are compatible with locally recognized standards.

Original test data is the key to the evidence chain. Many manufacturers only realize during deficiency requests that they need to provide test curves, raw records, sample descriptions, environmental conditions, etc. If these were not archived, reuse may fail.

Local adaptation includes translating report summaries and key results, converting technical units to those used in the target country, adjusting labels and instructions for language and symbols, updating power plug and rated voltage information, and adding country-specific requirements such as language, measurement units, and warning signs.

Common Mistakes

Assuming CE reports are globally accepted and ignoring the target country's accepted standard versions and laboratory scopes.
Ignoring differences in power supply systems between countries, making electrical safety results non-reusable.
Using an ISO 10993 version not recognized by the target country and failing to update documentation or perform supplementary testing.
Combining test reports with a model that differs from the actual registered model.
Overlooking the impact of software changes on test report validity, e.g., upgraded treatment parameter software without revalidation.
Registering with a certificate holder that differs from the report issuer without a legal transfer agreement.
Failing to keep raw data and complete test records, making it impossible to respond to deficiency requests.
Focusing only on the initial registration and neglecting post-market surveillance, change notifications, and renewal requirements.

Enterprise Preparation Checklist

Establish a product technical file that includes all versions of technical requirements, change records, and traceability relationships.
Compile a list of existing test reports, including report number, laboratory, standard version, report date, and corresponding model.
Conduct a target-country regulatory gap analysis, either with internal regulatory staff or by engaging a professional consultancy.
Confirm the target country's requirements for laboratory qualifications and communicate with authorities in advance when necessary.
Evaluate the need for supplementary testing, especially for electrical safety, EMC, biocompatibility, and performance verification.
Prepare local agent or authorized representative agreements and clearly define their obligations in reviewing registration files.
Create localized label and instruction manual versions and ensure language, units, and symbols comply with local regulations.
Review records of software, material, and process changes related to test reports and form an impact assessment.
Maintain complete original test data, ideally backed up in a traceable system.
Plan registration timelines and budgets, including deficiency risks and repeat testing costs, in project plans.

AIMEILI Regulatory Interpretation

Manufacturers often misunderstand the difference between a report being valid and being acceptable. A report may be valid under the original country's requirements, but the target country has independent acceptance rules.

Early in the project, perform a regulatory inventory of the target country. Do not rush to prepare translations or directly submit existing reports. A gap analysis that identifies supplementary testing needs can significantly reduce the likelihood of deficiency requests and associated costs.

Reusable elements are foundational data based on international standards and high-quality methodology, such as verification records under ISO 13485, IEC 60601 safety test results, and ISO 10993 biocompatibility conclusions. Items that must be localized include labels and instructions, local agent information, registration file formats, language requirements, some clinical evaluation conclusions, and assessments based on local clinical practice.

The local agent or authorized representative is not just a contact channel but also bears responsibility for certificate control, change notifications, and renewal obligations. Choose an agent with medical device regulatory capability and include the continuous update of test reports as a mandatory clause in the agent contract.

For multi-country registration, build a core technical documentation package that supports multiple registrations. Structurally store test reports, risk management documents, and clinical evidence so they can be assembled differently per target country, reducing duplicate work and deficiency risk.

Frequently Asked Questions

Do test reports have an expiration date?

Test reports typically do not have a fixed expiration date, but the standards on which they are based have a lifecycle. When standards are updated, the target country may require re-testing or supplementary assessment under the new standards. Routine reviews during the registration validity period may also require the latest report or a declaration that the product has not undergone substantive changes.

Can NMPA test reports be used directly for overseas registration?

It depends on whether the target country accepts reports from Chinese testing laboratories. Some countries with mutual recognition agreements or that accept CNAS-accredited laboratory data may accept them, but most require reports from locally recognized laboratories or from third-party laboratories that comply with ISO 17025. Ensure the standard versions and test methods in the report match the target country's requirements.

Does FDA clearance mean other countries will automatically accept the reports?

FDA clearance demonstrates compliance with US regulations but does not guarantee acceptance by other countries. Each country has its own technical review principles, especially for clinical evaluation, labeling, and intended use. However, the technical documentation from an FDA review can serve as strong foundational evidence and help accelerate technical evaluation.

Do we need to prepare multiple sets of test reports for multi-country registration?

It is not recommended to conduct full testing for every country due to cost. Instead, prepare one core test report and perform a gap analysis for each target country. Some countries may only require supplementary tests, such as high-temperature/humidity testing for tropical climates or tolerance testing for specific power systems.

If a design change occurs, can the original test reports still be used?

Design changes require an assessment of whether they affect safety or effectiveness. Depending on the nature of the change, no re-testing, partial supplementary testing, or full re-testing may be needed. Establish a change-to-report matrix to quickly determine the impact of any change on existing reports.

Need a registration pathway assessment?

Send product type, intended use, target countries and existing certificates. AIMEILI can help evaluate registration pathway, documentation gaps and compliance risks.

Contact AIMEILI

Can Test Reports Be Reused for Overseas Registration of Rehabilitation Devices?